Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_assertion type Assertion NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_head.
- NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_assertion description "[Polymorphism in GSTM3 may be an important biomarker for prostate cancer risk, especially in the definition of the genetic risk profile of populations of southern Europe.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_provenance.
- NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_assertion evidence source_evidence_literature NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_provenance.
- NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_assertion SIO_000772 14968442 NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_provenance.
- NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_assertion wasDerivedFrom lhgdn-20090331 NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_provenance.
- NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_assertion wasGeneratedBy ECO_0000203 NP203593.RAqnSvhaZY_pcu2tgpF18_xjQ7A0DFJj5x97irzFoGdtw130_provenance.